References
- Ohasi P S, Oehen S, Buerki K, Pircher H, Ohashi C T, Odermatt B, Malissen B, Zinkernagel R M, Hengartner H. Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991; 65: 305
- Oldstone M B, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991; 65: 319
- Sigurdsson E, Baekkeskov S. The 64-kDa beta cell membrane autoantigen and other target molecules of humoral autoimmunity in insulin-dependent diabetes mellitus. Curr Top Microbiol Immunol 1990; 164: 143
- Baekkeskov S, Warnock G, Christie M, Rajotte R V, Larson P M, Fey S. Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64K antigen. Diabetes 1989; 38: 1133
- Baekkeskov S, Aanstoot H J, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151
- Christgau S, Schierbeck H, Aanstoot H J, Aagaard L, Begley K, Kofod H, Hejnaes K, Baekkeskov S. Pancreatic beta cells express two autoantigenic forms of glutamic acid decarboxylase, a 65-kDa hydrophilic form and a 64-kDa Amphiphilic form which can be both membrane-bound and soluble. J of Biol Chem 1991; 266: 21257
- Erlander M G, Tillakaratne N JK, Feldblum S, Patel N, Tobin A J. Neuron 1991; 7: 91
- Aanstoot H J, Kim J, Knip M, Atkinson M, Mose-Larsen P, Fey S, Fu Q, Ludvigsson J, Landin M, Bruinings J, Maclaren N, Akerbloom H K, Baekkeskov S. 1993, Identification and characterization of a 38kD pancreatic (3-cell antigen which together with glutamic acid decarboxylase marks the early phases of autoimmune response in type 1 diabetes. Submitted
- Richter W, Endl J, Eiermann T H, Brandt M, Kientsch-Engel R, Thivolet C, Jungfer H, Scherbaum W A. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc Natl Acad Sci USA 1992; 89: 8467
- Richter W, Shi Y, Baekkeskov S. Autoreactive epitopes in glutamic acid decarboxylase defined by diabetes-associated human monoclonal antibodies. Proc Natl Acad Sci USA 1992; 90: 2832
- Kaufman D L, Erlander M G, Clare-Salzer M, Atkinson M A, Maclaren N K, Tobin A J. Autoimmunity of two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. Diabetes 1992; 889: 283
- Deaizpurua H J, Harrison L C, Cram D S. An ELISA for Antibodies to Recombinant Glutamic Acid Decarboxylase in IDDM. Diabetes 1992; 41: 1182
- Hagopian W A, Michelsen B, Karlsen A E, Larsen F, Moody A, Grubin C E, Rowe R, Petersen J, McEvoy R, Lernmark A. Autoantibodies in IDDM Primarily Recognize the 65,0OO-Mr Rather Than the 67,000-Mr Isoform of Glutamic Acid Decarboxylase. Diabetes 1993; 42: 631
- Christgau S, Aanstoot H J, Schierbeck H, Begley K, Tullin S, Hegnaes K, Baekkeskov S. Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta cells by palmitoylation on the NH2-Terminal domain. J Cell Biol 1992; 118: 309
- Deres K, Schild H, Wiesmiiller K H, Jung G, Rammensee H G. In vivo, priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 1989; 342: 561
- Robinson J H, Case M C, Brooks C G. Palmitic acid conjugation of a protein antigen enhances major histocompatibility comples class II-restricted presentation to T cells. Immunology 1992; 76: 593